Anticoagulant patient information material is written at high readability levels

C A Estrada1, M M Hryniewicz, V B Higgs

  • 1East Carolina University Anticoagulation Clinic, Clinical Information Support Office, University Health Systems, Greenville, North Carolina, USA. estradac@mail.ecu.edu.

Stroke
|January 11, 2000
PubMed

Insights

Patient information on anticoagulants is too difficult for many to understand. Most brochures are written at a 10th-grade level, far above the recommended 6th-grade level for effective patient education.

Area of Science:

  • Pharmacology
  • Health Literacy
  • Patient Education

Background:

  • Warfarin therapy requires careful monitoring and dose adjustments.
  • Elderly patients, especially those with atrial fibrillation or prior stroke, may struggle with complex medical information.
  • Effective patient education materials are crucial for safe anticoagulant use.

Purpose of the Study:

  • To assess the readability of patient information materials for anticoagulant therapy.
  • To determine if current materials meet recommended literacy standards for patient comprehension.

Main Methods:

  • The SMOG grade formula was used to measure the readability of 50 patient brochures.
  • Brochures covered warfarin, atrial fibrillation, low-molecular-weight heparins, and related topics.
  • Materials were sourced from industry, health advocacy groups, and the internet.

Main Results:

  • The average readability level of the brochures was 10.7 grade.
  • No brochures met the recommended 6th-grade reading level or below.
  • 74% of materials were written at a 9th-12th grade level, and 14% were above 12th grade.

Conclusions:

  • Patient education materials for anticoagulants are generally written at a reading level too high for most patients.
  • There is a significant need for low-literacy patient brochures for individuals on anticoagulant therapy.
Abstract

Related Concept Videos

Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...